{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:09:09Z","timestamp":1792724949773,"version":"4.5.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T00:00:00Z","timestamp":1777680000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"vor","delay-in-days":4,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-50728-3","type":"journal-article","created":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T06:14:07Z","timestamp":1777702447000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Synthesis, biological evaluation and molecular docking studies of N-propylsulfonyl indole-linked hydrazinecarbothioamides as selective ecto-5\u2032-nucleotidase and NTPDase inhibitors"],"prefix":"10.1038","volume":"16","author":[{"given":"Zahra","family":"Batool","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shireen Mona","family":"Dutt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariya","family":"al-Rashida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolly Espindola","family":"Gelsleichter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Pelletier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"S\u00e9vigny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talha","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa A.","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajmal","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halil","family":"\u015eenol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rima D.","family":"Alharthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamshed","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahid","family":"Shafiq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,2]]},"reference":[{"issue":"1","key":"50728_CR1","doi-asserted-by":"publisher","first-page":"84","DOI":"10.2174\/1570159X15666170518151541","volume":"17","author":"I Grkovi\u0107","year":"2019","unstructured":"Grkovi\u0107, I., Drakuli\u0107, D., Martinovi\u0107, J. & Mitrovi\u0107, N. Role of ectonucleotidases in synapse formation during brain development: physiological and pathological implications. Curr. Neuropharmacol. 17 (1), 84\u201398 (2019).","journal-title":"Curr. Neuropharmacol."},{"issue":"5","key":"50728_CR2","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1039\/C7MD00015D","volume":"8","author":"S-Y Lee","year":"2017","unstructured":"Lee, S-Y. & M\u00fcller, C. E. Nucleotide pyrophosphatase\/phosphodiesterase 1 (NPP1) and its inhibitors. MedChemComm 8 (5), 823\u2013840 (2017).","journal-title":"MedChemComm"},{"key":"50728_CR3","doi-asserted-by":"publisher","first-page":"109770","DOI":"10.1016\/j.pnpbp.2019.109770","volume":"98","author":"DD Nabinger","year":"2020","unstructured":"Nabinger, D. D., Altenhofen, S. & Bonan, C. D. Zebrafish models: Gaining insight into purinergic signaling and neurological disorders. Prog. Neuropsychopharmacol. Biol. Psychiatry. 98, 109770 (2020).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"50728_CR4","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.3389\/fphar.2019.01689","volume":"10","author":"E Caiazzo","year":"2020","unstructured":"Caiazzo, E., Bilancia, R., Rossi, A., Ialenti, A. & Cicala, C. Ectonucleoside triphosphate diphosphohydrolase-1\/CD39 affects the response to ADP of female rat platelets. Front. Pharmacol. 10, 1689 (2020).","journal-title":"Front. Pharmacol."},{"issue":"1","key":"50728_CR5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2174\/1389557515666150219115141","volume":"15","author":"Y Baqi","year":"2015","unstructured":"Baqi, Y. Ecto-nucleotidase inhibitors: recent developments in drug discovery. Mini Rev. Med. Chem. 15 (1), 21\u201333 (2015).","journal-title":"Mini Rev. Med. Chem."},{"issue":"11","key":"50728_CR6","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1161\/ATVBAHA.115.303395","volume":"35","author":"B Hechler","year":"2015","unstructured":"Hechler, B. & Gachet, C. Purinergic receptors in thrombosis and inflammation. Arterioscler. Thromb. Vasc. Biol. 35 (11), 2307\u20132315 (2015).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"50728_CR7","first-page":"4892473","volume":"2018","author":"MD Bagatini","year":"2018","unstructured":"Bagatini, M. D. et al. The impact of purinergic system enzymes on noncommunicable, neurological, and degenerative diseases. J. Immunol. Res. 2018 (1), 4892473 (2018).","journal-title":"J. Immunol. Res."},{"issue":"3","key":"50728_CR8","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.cmet.2018.10.007","volume":"29","author":"DC Saunders","year":"2019","unstructured":"Saunders, D. C. et al. Ectonucleoside triphosphate diphosphohydrolase-3 antibody targets adult human pancreatic \u03b2 cells for in vitro and in vivo analysis. Cell Metabol. 29 (3), 745\u2013754 (2019). e4.","journal-title":"Cell Metabol."},{"key":"50728_CR9","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s11302-017-9587-y","volume":"13","author":"AH Zhong","year":"2017","unstructured":"Zhong, A. H., Gordon Jiang, Z., Cummings, R. D. & Robson, S. C. Various N-glycoforms differentially upregulate E-NTPDase activity of the NTPDase3\/CD39L3 ecto-enzymatic domain. Purinergic Signal. 13, 601\u2013609 (2017).","journal-title":"Purinergic Signal."},{"issue":"4","key":"50728_CR10","doi-asserted-by":"publisher","first-page":"G447","DOI":"10.1152\/ajpgi.00165.2011","volume":"302","author":"M Fausther","year":"2012","unstructured":"Fausther, M. et al. Coexpression of ecto-5\u2032-nucleotidase\/CD73 with specific NTPDases differentially regulates adenosine formation in the rat liver. Am. J. Physiology-Gastrointestinal Liver Physiol. 302 (4), G447\u2013G59 (2012).","journal-title":"Am. J. Physiology-Gastrointestinal Liver Physiol."},{"key":"50728_CR11","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s11302-012-9309-4","volume":"8","author":"H Zimmermann","year":"2012","unstructured":"Zimmermann, H., Zebisch, M. & Str\u00e4ter, N. Cellular function and molecular structure of ecto-nucleotidases. Purinergic Signal. 8, 437\u2013502 (2012).","journal-title":"Purinergic Signal."},{"key":"50728_CR12","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s00109-012-0991-z","volume":"91","author":"MS Longhi","year":"2013","unstructured":"Longhi, M. S., Robson, S. C., Bernstein, S. H., Serra, S. & Deaglio, S. Biological functions of ecto-enzymes in regulating extracellular adenosine levels in neoplastic and inflammatory disease states. J. Mol. Med. 91, 165\u2013172 (2013).","journal-title":"J. Mol. Med."},{"issue":"3","key":"50728_CR13","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/cdd.2016.159","volume":"24","author":"PS Murphy","year":"2017","unstructured":"Murphy, P. S. et al. CD73 regulates anti-inflammatory signaling between apoptotic cells and endotoxin-conditioned tissue macrophages. Cell. Death Differ. 24 (3), 559\u2013570 (2017).","journal-title":"Cell. Death Differ."},{"issue":"4","key":"50728_CR14","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1080\/21688370.2016.1224963","volume":"4","author":"JL Bowser","year":"2016","unstructured":"Bowser, J. L. & Broaddus, R. R. CD73s protection of epithelial integrity: thinking beyond the barrier. Tissue Barriers. 4 (4), 220\u2013238 (2016).","journal-title":"Tissue Barriers"},{"issue":"4","key":"50728_CR15","doi-asserted-by":"publisher","first-page":"647","DOI":"10.18388\/abp.2012_2105","volume":"59","author":"R Sadej","year":"2012","unstructured":"Sadej, R. & Skladanowski, A. Dual, enzymatic and non-enzymatic, function of ecto-5\u2019-nucleotidase (eN, CD73) in migration and invasion of A375 melanoma cells. Acta Biochim. Pol. 59 (4), 647\u2013652 (2012).","journal-title":"Acta Biochim. Pol."},{"issue":"9","key":"50728_CR16","doi-asserted-by":"publisher","first-page":"e70098","DOI":"10.1002\/ardp.70098","volume":"358","author":"H Aftab","year":"2025","unstructured":"Aftab, H. et al. Synthesis, Biological Evaluation and Molecular Docking Studies of Novel 4-Propylsulfonylpiperazines\u2010Based Thiosemicarbazones as Ecto\u20105\u2032\u2010Nucleotidase and NTPDase Inhibitors. Arch. Pharm. 358 (9), e70098 (2025).","journal-title":"Arch. Pharm."},{"key":"50728_CR17","doi-asserted-by":"crossref","unstructured":"Batool, Z. et al. N-hexylsulfonyl indole based thiosemicarbazones as potent and selective ecto-5\u2032-nucleotidase and NTPDase inhibitors. Bioorg. Chem. 163, 108717 (2025).","DOI":"10.1016\/j.bioorg.2025.108717"},{"issue":"42","key":"50728_CR18","doi-asserted-by":"publisher","first-page":"29496","DOI":"10.1039\/D3RA04266A","volume":"13","author":"MSK Jadoon","year":"2023","unstructured":"Jadoon, M. S. K., Pelletier, J., S\u00e9vigny, J. & Iqbal, J. Synthesis of new class of indole acetic acid sulfonate derivatives as ectonucleotidases inhibitors. RSC Adv. 13 (42), 29496\u201329511 (2023).","journal-title":"RSC Adv."},{"key":"50728_CR19","doi-asserted-by":"publisher","first-page":"105240","DOI":"10.1016\/j.bioorg.2021.105240","volume":"115","author":"A Murtaza","year":"2021","unstructured":"Murtaza, A. et al. Divergent synthesis and elaboration of structure activity relationship for quinoline derivatives as highly selective NTPDase inhibitor. Bioorg. Chem. 115, 105240 (2021).","journal-title":"Bioorg. Chem."},{"key":"50728_CR20","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11302-019-09686-x","volume":"16","author":"JB Willig","year":"2020","unstructured":"Willig, J. B. et al. Imatinib mesylate affects extracellular ATP catabolism and expression of NTPDases in a chronic myeloid leukemia cell line. Purinergic Signal. 16, 29\u201340 (2020).","journal-title":"Purinergic Signal."},{"key":"50728_CR21","unstructured":"Ate\u015fo\u011flu, \u015e. et al. Synthesis, Characterization and In Vitro and In Silico Biological Evaluation of New Mannich-Based Rhodanine and Thiazolidine-2, 4-dione Derivatives as Potential Anti-Lung-Cancer Agents. Synlett. (2025)."},{"issue":"39","key":"50728_CR22","doi-asserted-by":"publisher","first-page":"28524","DOI":"10.1039\/D4RA05015K","volume":"14","author":"Z Batool","year":"2024","unstructured":"Batool, Z. et al. Design, synthesis, and in vitro and in silico study of 1-benzyl-indole hybrid thiosemicarbazones as competitive tyrosinase inhibitors. RSC Adv. 14 (39), 28524\u201328542 (2024).","journal-title":"RSC Adv."},{"issue":"7","key":"50728_CR23","doi-asserted-by":"publisher","first-page":"e70034","DOI":"10.1002\/ardp.70034","volume":"358","author":"U Ghaffar","year":"2025","unstructured":"Ghaffar, U. et al. Synthesis, Anti-Alzheimer Evaluation and In Silico Study of 4\u2010Methoxyphenyl) Sulfonyl Indole Hybrid Thiosemicarbazones. Arch. Pharm. 358 (7), e70034 (2025).","journal-title":"Arch. Pharm."},{"issue":"7","key":"50728_CR24","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.3390\/pharmaceutics15071815","volume":"15","author":"E Russo","year":"2023","unstructured":"Russo, E. et al. Indole antitumor agents in nanotechnology formulations: an overview. Pharmaceutics 15 (7), 1815 (2023).","journal-title":"Pharmaceutics"},{"key":"50728_CR25","doi-asserted-by":"publisher","first-page":"135477","DOI":"10.1016\/j.molstruc.2023.135477","volume":"1285","author":"M Hawash","year":"2023","unstructured":"Hawash, M. et al. Novel indole-pyrazole hybrids as potential tubulin-targeting agents; Synthesis, antiproliferative evaluation, and molecular modeling studies. J. Mol. Struct. 1285, 135477 (2023).","journal-title":"J. Mol. Struct."},{"issue":"16","key":"50728_CR26","doi-asserted-by":"publisher","first-page":"3332","DOI":"10.2174\/0115701808288928240226104445","volume":"21","author":"MR Mohamed","year":"2024","unstructured":"Mohamed, M. R., Shoman, M. E., Ali, T. F. & Abuo-Rahma, G. E. D. A. Anti-tumor Activity of Indole: A Review. Lett. Drug Des. Discovery. 21 (16), 3332\u20133348 (2024).","journal-title":"Lett. Drug Des. Discovery"},{"key":"50728_CR27","doi-asserted-by":"crossref","unstructured":"Anuradha, M. A. & Sharma, S. Indole as an emerging scaffold in anticancer drug design. AIP Conference Proceedings: AIP Publishing LLC; p. 020198. (2023).","DOI":"10.1063\/5.0169005"},{"issue":"4","key":"50728_CR28","doi-asserted-by":"publisher","first-page":"372","DOI":"10.2174\/0115733947249518231001001728","volume":"20","author":"M Rana","year":"2024","unstructured":"Rana, M., Ranjan, R., Sekhar Ghosh, N., Kumar, D. & Singh, R. A Review on Indole as a Cardinal Scaffold for Anticancer Drugs Development. Curr. Cancer Therapy Reviews. 20 (4), 372\u2013385 (2024).","journal-title":"Curr. Cancer Therapy Reviews"},{"issue":"34","key":"50728_CR29","doi-asserted-by":"publisher","first-page":"e202202361","DOI":"10.1002\/slct.202202361","volume":"7","author":"A Mehra","year":"2022","unstructured":"Mehra, A. et al. Indole derived anticancer agents. ChemistrySelect 7 (34), e202202361 (2022).","journal-title":"ChemistrySelect"},{"key":"50728_CR30","doi-asserted-by":"crossref","unstructured":"Batool, Z. et al. Dual targeting of neuroblastoma and cholinesterase by morpholino\/pyrrolidino-sulfonyl-indole thiosemicarbazones: Synthesis, characterization, enzyme inhibition, cytotoxicity, docking and dynamics studies. Bioorg. Chem. 167, 109252. (2025).","DOI":"10.1016\/j.bioorg.2025.109252"},{"key":"50728_CR31","doi-asserted-by":"publisher","unstructured":"Tokali, F. S., \u015eenol, H., Ate\u015fo\u011flu, \u015e., Tokal\u0131, P. & Akba\u015f, F. Design, synthesis, and cytotoxic evaluation of new thiosemicarbazone\/thiazolidin-4-one derivatives on PC3 cells. Future Med. Chem. 1\u201312. https:\/\/doi.org\/10.1080\/17568919.2025.2592533 (2025).","DOI":"10.1080\/17568919.2025.2592533"},{"issue":"9","key":"50728_CR32","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.3390\/molecules30092077","volume":"30","author":"O Garbuz","year":"2025","unstructured":"Garbuz, O. et al. Thiosemicarbazone-Based Compounds: Cancer Cell Inhibitors with Antioxidant Properties. Molecules 30 (9), 2077 (2025).","journal-title":"Molecules"},{"issue":"2","key":"50728_CR33","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3390\/biom12020151","volume":"12","author":"P Kozyra","year":"2022","unstructured":"Kozyra, P. et al. Potential anticancer agents against melanoma cells based on an as-synthesized thiosemicarbazide derivative. Biomolecules 12 (2), 151 (2022).","journal-title":"Biomolecules"},{"issue":"3","key":"50728_CR34","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1021\/acs.organomet.2c00604","volume":"42","author":"N Balakrishnan","year":"2023","unstructured":"Balakrishnan, N. et al. Influence of Indole-N substitution of thiosemicarbazones in cationic Ru (II)(\u03b76-Benzene) complexes on their anticancer activity. Organometallics 42 (3), 259\u2013275 (2023).","journal-title":"Organometallics"},{"issue":"10","key":"50728_CR35","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.3390\/biomedicines9101375","volume":"9","author":"BZ Sibuh","year":"2021","unstructured":"Sibuh, B. Z. et al. Synthesis, in silico study, and anti-cancer activity of thiosemicarbazone derivatives. Biomedicines 9 (10), 1375 (2021).","journal-title":"Biomedicines"},{"key":"50728_CR36","unstructured":"PapeVeronika, F., Enyedy\u00c9va, A., KepplerBernhard, K. & KowolChristian, R. Anticancer thiosemicarbazones: chemical properties, interaction with iron metabolism, and resistance development (Antioxidants & redox signaling, 2019)."},{"key":"50728_CR37","doi-asserted-by":"publisher","first-page":"111134","DOI":"10.1016\/j.jinorgbio.2020.111134","volume":"210","author":"NK Singh","year":"2020","unstructured":"Singh, N. K., Kumbhar, A. A., Pokharel, Y. R. & Yadav, P. N. Anticancer potency of copper (II) complexes of thiosemicarbazones. J. Inorg. Biochem. 210, 111134 (2020).","journal-title":"J. Inorg. Biochem."},{"key":"50728_CR38","doi-asserted-by":"publisher","first-page":"114218","DOI":"10.1016\/j.poly.2019.114218","volume":"175","author":"SJ Sardroud","year":"2020","unstructured":"Sardroud, S. J., Hosseini-Yazdi, S. A., Mahdavi, M., Poupon, M. & Skorepova, E. Synthesis, characterization and in vitro evaluation of anticancer activity of a new water-soluble thiosemicarbazone ligand and its complexes. Polyhedron 175, 114218 (2020).","journal-title":"Polyhedron"},{"key":"50728_CR39","doi-asserted-by":"publisher","first-page":"135494","DOI":"10.1016\/j.molstruc.2023.135494","volume":"1285","author":"V Manakkadan","year":"2023","unstructured":"Manakkadan, V. et al. Synthesis and characterization of N4-substituted thiosemicarbazones: DNA\/BSA binding, molecular docking, anticancer activity, ADME study and computational investigations. J. Mol. Struct. 1285, 135494 (2023).","journal-title":"J. Mol. Struct."},{"issue":"33","key":"50728_CR40","doi-asserted-by":"publisher","first-page":"15748","DOI":"10.1039\/D3NJ02067C","volume":"47","author":"J Haribabu","year":"2023","unstructured":"Haribabu, J. et al. Michael addition-driven synthesis of cytotoxic palladium (ii) complexes from chromone thiosemicarbazones: investigation of anticancer activity through in vitro and in vivo studies. New J. Chem. 47 (33), 15748\u201315759 (2023).","journal-title":"New J. Chem."},{"key":"50728_CR41","doi-asserted-by":"publisher","first-page":"136700","DOI":"10.1016\/j.molstruc.2023.136700","volume":"1295","author":"K Preetha","year":"2024","unstructured":"Preetha, K., Seena, E., Maniyampara, P. K., Manoj, E. & Kurup, M. P. Synthesis, crystal structure, Hirshfeld surface analysis, DFT, molecular docking and in vitro antitumor studies of (2E)-2-[4-(diethylamino) benzylidene]-N-ethylhydrazinecarbothioamide. J. Mol. Struct. 1295, 136700 (2024).","journal-title":"J. Mol. Struct."},{"issue":"4","key":"50728_CR42","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1002\/jhet.4619","volume":"60","author":"FS Tokal\u0131","year":"2023","unstructured":"Tokal\u0131, F. S., \u015eenol, H., Katmerlikaya, T. G., Da\u011f, A. & \u015eendil, K. Novel thiosemicarbazone and thiazolidin-4\u2010one derivatives containing vanillin core: Synthesis, characterization, and anticancer activity studies. J. Heterocycl. Chem. 60 (4), 645\u2013656. https:\/\/doi.org\/10.1002\/jhet.4619 (2023).","journal-title":"J. Heterocycl. Chem."},{"key":"50728_CR43","doi-asserted-by":"publisher","unstructured":"Tokal\u0131, F. S., Taslimi, P., Usanmaz, H., Karaman, M. & Sendil, K. Synthesis, characterization, biological activity and molecular docking studies of novel schiff bases derived from thiosemicarbazide: Biochemical and computational approach. J. Mol. Struct. 1231 https:\/\/doi.org\/10.1016\/j.molstruc.2020.129666 (2021).","DOI":"10.1016\/j.molstruc.2020.129666"},{"issue":"7","key":"50728_CR44","doi-asserted-by":"publisher","first-page":"e70048","DOI":"10.1002\/ardp.70048","volume":"358","author":"H \u015eenol","year":"2025","unstructured":"\u015eenol, H. et al. 2-Propyl\u20103\u2010Aminoquinazoline\u20104 (3H)\u2010one Derivatives as Potential Androgen Receptor Inhibitors: Synthesis and Cytotoxicity Against PC3 Cell Line via In Vitro and In Silico Studies. Arch. Pharm. 358 (7), e70048 (2025).","journal-title":"Arch. Pharm."},{"key":"50728_CR45","doi-asserted-by":"publisher","first-page":"585876","DOI":"10.3389\/fphar.2020.585876","volume":"11","author":"S Afzal","year":"2020","unstructured":"Afzal, S. et al. Functionalized oxoindolin hydrazine carbothioamide derivatives as highly potent inhibitors of nucleoside triphosphate diphosphohydrolases. Front. Pharmacol. 11, 585876 (2020).","journal-title":"Front. Pharmacol."},{"issue":"30","key":"50728_CR46","doi-asserted-by":"publisher","first-page":"20909","DOI":"10.1039\/D3RA03874B","volume":"13","author":"ZH Zaigham","year":"2023","unstructured":"Zaigham, Z. H. et al. Synthesis and biological evaluation of sulfamoyl benzamide derivatives as selective inhibitors for h-NTPDases. RSC Adv. 13 (30), 20909\u201320915 (2023).","journal-title":"RSC Adv."},{"key":"50728_CR47","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.bioorg.2018.10.046","volume":"82","author":"KM Khan","year":"2019","unstructured":"Khan, K. M. et al. Schiff bases of tryptamine as potent inhibitors of nucleoside triphosphate diphosphohydrolases (NTPDases): structure-activity relationship. Bioorg. Chem. 82, 253\u2013266 (2019).","journal-title":"Bioorg. Chem."},{"key":"50728_CR48","doi-asserted-by":"publisher","first-page":"131068","DOI":"10.1016\/j.ijbiomac.2024.131068","volume":"266","author":"M Tasleem","year":"2024","unstructured":"Tasleem, M. et al. Synthesis, in vitro, and in silico studies of morpholine-based thiosemicarbazones as ectonucleotide pyrophosphatase\/phosphodiesterase-1 and-3 inhibitors. Int. J. Biol. Macromol. 266, 131068 (2024).","journal-title":"Int. J. Biol. Macromol."},{"issue":"8","key":"50728_CR49","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1016\/j.bmcl.2012.02.042","volume":"22","author":"Y Zou","year":"2012","unstructured":"Zou, Y. et al. New triazole derivatives as antifungal agents: Synthesis via click reaction, in vitro evaluation and molecular docking studies. Bioorg. Med. Chem. Lett. 22 (8), 2959\u20132962 (2012).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"50728_CR50","doi-asserted-by":"publisher","first-page":"140702","DOI":"10.1016\/j.molstruc.2024.140702","volume":"1322","author":"F \u00c7ak\u0131r","year":"2025","unstructured":"\u00c7ak\u0131r, F. et al. Novel 4-((3-fluorobenzyl)oxy)benzohydrazide derivatives as promising anti-prostate cancer agents: Synthesis, characterization and in vitro & in silico biological activity studies. J. Mol. Struct. 1322, 140702. https:\/\/doi.org\/10.1016\/j.molstruc.2024.140702 (2025).","journal-title":"J. Mol. Struct."},{"key":"50728_CR51","doi-asserted-by":"publisher","first-page":"118060","DOI":"10.1016\/j.bmc.2025.118060","volume":"119","author":"B Zengin Kurt","year":"2025","unstructured":"Zengin Kurt, B., \u00d6zmen, \u00d6., \u00d6zt\u00fcrk Civelek, D., \u015eenol, H. & Sonmez, F. Exploring anticancer properties of new triazole-linked benzenesulfonamide derivatives against colorectal carcinoma: Synthesis, cytotoxicity, and in silico insights. Bioorg. Med. Chem. 119, 118060. https:\/\/doi.org\/10.1016\/j.bmc.2025.118060 (2025).","journal-title":"Bioorg. Med. Chem."},{"issue":"10","key":"50728_CR52","doi-asserted-by":"publisher","first-page":"e70116","DOI":"10.1002\/ardp.70116","volume":"358","author":"S Raza","year":"2025","unstructured":"Raza, S. et al. Targeting Lung Cancer: Synthesis, Characterization, Enzyme Inhibition, and Antiproliferative Activity of 1H-Benzo[f]chromen-1-One-Thiosemicarbazones Supported by Molecular Docking. Arch. Pharm. 358 (10), e70116. https:\/\/doi.org\/10.1002\/ardp.70116 (2025).","journal-title":"Arch. Pharm."},{"issue":"39","key":"50728_CR53","doi-asserted-by":"publisher","first-page":"e202302448","DOI":"10.1002\/slct.202302448","volume":"8","author":"H \u015eenol","year":"2023","unstructured":"\u015eenol, H. & \u00c7ak\u0131r, F. 3-Amino-thiophene-2-carbohydrazide Derivatives as Anti Colon Cancer Agents: Synthesis, Characterization, In-Silico and In-Vitro. Biol. Activity Stud. ChemistrySelect. 8 (39), e202302448. https:\/\/doi.org\/10.1002\/slct.202302448 (2023).","journal-title":"Biol. Activity Stud. ChemistrySelect"},{"key":"50728_CR54","doi-asserted-by":"publisher","unstructured":"Halder, D., Banerjee, S., Biswas, S., Adhikari, N. & Ghosh, B. Molecular modeling to simulation: insights into Gaussian QSAR, molecular docking, and DFT for identification of HDAC3 inhibitors for neurocognitive vascular dementia. Sci. Rep. 15 https:\/\/doi.org\/10.1038\/s41598-025-28304-y (2025).","DOI":"10.1038\/s41598-025-28304-y"},{"key":"50728_CR55","doi-asserted-by":"publisher","first-page":"105660","DOI":"10.1016\/j.cmpb.2020.105660","volume":"195","author":"K Al-Khafaji","year":"2020","unstructured":"Al-Khafaji, K. & Taskin Tok, T. Molecular dynamics simulation, free energy landscape and binding free energy computations in exploration the anti-invasive activity of amygdalin against metastasis. Comput. Methods Programs Biomed. 195, 105660. https:\/\/doi.org\/10.1016\/j.cmpb.2020.105660 (2020).","journal-title":"Comput. Methods Programs Biomed."},{"issue":"1","key":"50728_CR56","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s11030-024-10837-5","volume":"29","author":"G Lanka","year":"2025","unstructured":"Lanka, G., Banerjee, S., Adhikari, N. & Ghosh, B. Fragment-based discovery of new potential DNMT1 inhibitors integrating multiple pharmacophore modeling, 3D-QSAR, virtual screening, molecular docking, ADME, and molecular dynamics simulation approaches. Mol. Divers. 29 (1), 117\u2013137. https:\/\/doi.org\/10.1007\/s11030-024-10837-5 (2025).","journal-title":"Mol. Divers."},{"issue":"4","key":"50728_CR57","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1080\/17568919.2026.2620368","volume":"18","author":"P Tokal\u0131","year":"2026","unstructured":"Tokal\u0131, P. et al. New quinazolinone-thiazolidinedione hybrids as selective anti-lung cancer agents and promising EGFR inhibitors. Future Med. Chem. 18 (4), 415\u2013428. https:\/\/doi.org\/10.1080\/17568919.2026.2620368 (2026).","journal-title":"Future Med. Chem."},{"key":"50728_CR58","doi-asserted-by":"publisher","first-page":"109778","DOI":"10.1016\/j.bioorg.2026.109778","volume":"175","author":"FS Tokal\u0131","year":"2026","unstructured":"Tokal\u0131, F. S. et al. Targeting cholinergic dysfunction and neuroinflammation through rationally designed Thieno[3,2-d]pyrimidine hybrids. Bioorg. Chem. 175, 109778. https:\/\/doi.org\/10.1016\/j.bioorg.2026.109778 (2026).","journal-title":"Bioorg. Chem."},{"issue":"51","key":"50728_CR59","doi-asserted-by":"publisher","first-page":"33116","DOI":"10.1074\/jbc.271.51.33116","volume":"271","author":"E Kaczmarek","year":"1996","unstructured":"Kaczmarek, E. et al. Identification and characterization of CD39\/vascular ATP diphosphohydrolase. J. Biol. Chem. 271 (51), 33116\u201333122 (1996).","journal-title":"J. Biol. Chem."},{"issue":"2","key":"50728_CR60","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.abb.2003.08.007","volume":"418","author":"AF Knowles","year":"2003","unstructured":"Knowles, A. F. & Chiang, W-C. Enzymatic and transcriptional regulation of human ecto-ATPase\/E-NTPDase 2. Arch. Biochem. Biophys. 418 (2), 217\u2013227 (2003).","journal-title":"Arch. Biochem. Biophys."},{"key":"50728_CR61","doi-asserted-by":"crossref","unstructured":"Smith, T. M. & Kirley, T. L. Cloning, sequencing, and expression of a human brain ecto-apyrase related to both the ecto-ATPases and CD39 ecto-apyrases1. Biochim Biophys Acta. 1386(1), 65\u201378. (1998). doi: 10.1016\/s0167-4838(98)00063-6","DOI":"10.1016\/S0167-4838(98)00063-6"},{"issue":"3","key":"50728_CR62","doi-asserted-by":"publisher","first-page":"G785","DOI":"10.1152\/ajpgi.00293.2006","volume":"292","author":"M Fausther","year":"2007","unstructured":"Fausther, M. et al. Cloning, purification, and identification of the liver canalicular ecto-ATPase as NTPDase8. Am. J. Physiology-Gastrointestinal Liver Physiol. 292 (3), G785\u2013G95 (2007).","journal-title":"Am. J. Physiology-Gastrointestinal Liver Physiol."},{"issue":"5","key":"50728_CR63","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1111\/j.1476-5381.2010.00951.x","volume":"161","author":"J Lecka","year":"2010","unstructured":"Lecka, J., Rana, M. S. & S\u00e9vigny, J. Inhibition of vascular ectonucleotidase activities by the pro-drugs ticlopidine and clopidogrel favours platelet aggregation. Br. J. Pharmacol. 161 (5), 1150\u20131160 (2010).","journal-title":"Br. J. Pharmacol."},{"key":"50728_CR64","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s11302-005-6217-x","volume":"1","author":"F Kukulski","year":"2005","unstructured":"Kukulski, F. et al. Comparative hydrolysis of P2 receptor agonists by NTPDases 1, 2, 3 and 8. Purinergic Signal. 1, 193\u2013204 (2005).","journal-title":"Purinergic Signal."},{"key":"50728_CR65","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3389\/fphar.2018.00153","volume":"9","author":"M Adzic","year":"2018","unstructured":"Adzic, M. & Nedeljkovic, N. Unveiling the role of ecto-5\u2032-nucleotidase\/CD73 in astrocyte migration by using pharmacological tools. Front. Pharmacol. 9, 153 (2018).","journal-title":"Front. Pharmacol."},{"key":"50728_CR66","doi-asserted-by":"publisher","first-page":"116672","DOI":"10.1016\/j.bmc.2022.116672","volume":"59","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y. et al. Discovery and optimization of betulinic acid derivatives as novel potent CD73 inhibitors. Bioorg. Med. Chem. 59, 116672. https:\/\/doi.org\/10.1016\/j.bmc.2022.116672 (2022).","journal-title":"Bioorg. Med. Chem."},{"issue":"4","key":"50728_CR67","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s11302-021-09802-w","volume":"17","author":"E Scaletti","year":"2021","unstructured":"Scaletti, E., Huschmann, F. U., Mueller, U., Weiss, M. S. & Str\u00e4ter, N. Substrate binding modes of purine and pyrimidine nucleotides to human ecto-5\u2032-nucleotidase (CD73) and inhibition by their bisphosphonic acid derivatives. Purinergic Signal. 17 (4), 693\u2013704. https:\/\/doi.org\/10.1007\/s11302-021-09802-w (2021).","journal-title":"Purinergic Signal."},{"key":"50728_CR68","unstructured":"Release, S. 4: Desmond molecular dynamics system (DE Shaw Research, 2017)."},{"issue":"1","key":"50728_CR69","doi-asserted-by":"publisher","first-page":"e70666","DOI":"10.1002\/jbt.70666","volume":"40","author":"\u00d6\u00d6 Acar","year":"2026","unstructured":"Acar, \u00d6. \u00d6. et al. A Small Indole Derivative Isolated From Caper (Capparis ovata) as an Inducer of P53-Mediated Apoptosis in Prostate Cancer: Comprehensive In Vitro and In Silico Studies. J. Biochem. Mol. Toxic. 40 (1), e70666. https:\/\/doi.org\/10.1002\/jbt.70666 (2026).","journal-title":"J. Biochem. Mol. Toxic."},{"key":"50728_CR70","doi-asserted-by":"publisher","first-page":"109364","DOI":"10.1016\/j.bioorg.2025.109364","volume":"168","author":"H Aftab","year":"2026","unstructured":"Aftab, H. et al. A series of 4-thiomorpholinophenyl-thiosemicarbazones as cholinesterase inhibitors with anti-neuroblastoma effects. Bioorg. Chem. 168, 109364. https:\/\/doi.org\/10.1016\/j.bioorg.2025.109364 (2026).","journal-title":"Bioorg. Chem."},{"issue":"1","key":"50728_CR71","doi-asserted-by":"publisher","first-page":"e14599","DOI":"10.1111\/cbdd.14599","volume":"104","author":"FS Tokal\u0131","year":"2024","unstructured":"Tokal\u0131, F. S., \u015eenol, H., Ateoglu, \u015e. & Akba\u015f, F. A series of quinazolin-4(3H)-one-morpholine hybrids as anti-lung-cancer agents: Synthesis, molecular docking, molecular dynamics, ADME prediction and biological activity studies. Chem. Biol. Drug Des. 104 (1), e14599. https:\/\/doi.org\/10.1111\/cbdd.14599 (2024).","journal-title":"Chem. Biol. Drug Des."},{"key":"50728_CR72","doi-asserted-by":"publisher","first-page":"139519","DOI":"10.1016\/j.molstruc.2024.139519","volume":"1319","author":"FS Tokal\u0131","year":"2025","unstructured":"Tokal\u0131, F. S., \u015eenol, H., Ate\u015fo\u011flu, \u015e., Tokal\u0131, P. & Akba\u015f, F. Exploring highly selective polymethoxy fenamate isosteres as novel anti-prostate cancer agents: Synthesis, biological activity, molecular docking, molecular dynamics, and ADME studies. J. Mol. Struct. 1319, 139519. https:\/\/doi.org\/10.1016\/j.molstruc.2024.139519 (2025).","journal-title":"J. Mol. Struct."},{"issue":"2","key":"50728_CR73","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s13738-021-02331-8","volume":"19","author":"FS Tokal\u0131","year":"2022","unstructured":"Tokal\u0131, F. S. et al. Novel phenolic Mannich base derivatives: synthesis, bioactivity, molecular docking, and ADME-Tox Studies. J. Iran. Chem. Soc. 19 (2), 563\u2013577. https:\/\/doi.org\/10.1007\/s13738-021-02331-8 (2022).","journal-title":"J. Iran. Chem. Soc."},{"issue":"11","key":"50728_CR74","doi-asserted-by":"publisher","first-page":"996","DOI":"10.2174\/1570180819666211230123145","volume":"19","author":"N K\u0131l\u0131n\u00e7","year":"2022","unstructured":"K\u0131l\u0131n\u00e7, N., A\u00e7ar, M., Tuncay, S. & Karasakal, \u00d6. F. Identification of Potential Inhibitors for Severe Acute Respiratory Syndrome-related Coronavirus 2 (SARS-CoV-2) Angiotensin-converting Enzyme 2 and the Main Protease from Anatolian Traditional Plants. Lett. Drug Des. Discov. 19 (11), 996\u20131006. https:\/\/doi.org\/10.2174\/1570180819666211230123145 (2022).","journal-title":"Lett. Drug Des. Discov"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50728-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50728-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50728-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T19:02:26Z","timestamp":1778094146000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50728-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,2]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["50728"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-50728-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,2]]},"assertion":[{"value":"10 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14419"}}